- > English
- > Patients & Families
- > Hospital Introduction
- > Hospital Divisions
- > Center for Maternal-Fetal
- > Division of Reproductive Medicine and Maternal Care / Immunology
Division of Reproductive Medicine and Maternal Care / Immunology
While there are only a few hospitals specializing in recurrent pregnancy loss (RPL) in Japan, our division has independently conducted research on infertility since its establishment in 2002. We comprehensively support research into the causes of RPL and the development of fertility treatments, as well as manage the care and treatment for women from the establishment of pregnancy to delivery in collaboration with the obstetrics, fetal diagnosis, infertility diagnosis, maternal medicine and clinical genetics departments.
Specialist physicians from the Japan Society of Obstetrics and Gynecology and the Japan Society of Perinatal and Neonatal Medicine provide medical examinations at our specialized outpatient department four times a week. We offer fertility testing and review test items annually, and revise them as required by taking into account the latest findings.
Diagnosis and treatment policy
WWe make decisions for each patient separately based on medical evidence in consideration of the needs of patients and their families. In the event coagulat ion factor disorder or antiphospholipid antibody syndrome is diagnosed, we provide an antithrombotic regimen that includes oral administration of aspirin or heparin injection. Medical care is provided in close cooperation with the departments of obstetrics, fetal diagnosis, infertility diagnosis, maternal medicine and clinical genetics. The division also manages surgery in the event of miscarriage, and the diagnosis and management of stillbirth.
Pregnancy control for RPL patients
Investigating causes of RPL r
We provide first-rate treatment using the latest medical knowledge and by investigating possible underlying causes of miscarriage and stillbirth in order to improve the chances for a successful pregnancy.
- recurrent miscarriage
- early neonatal mortality
- Aspirin therapy
- Heparin therapy
- Immunoglobulin therapy